Additionally, we found higher expression of the CCAAT/enhancer-binding protein α (C/EBPα) (p < 0.05) and IL-6 (p < 0.01) in Ast-AD vs. Ast-Ctrl cells. This evidence concerns the gene CEBPA and Alzheimer disease.